Stoneridge Toekomstige groei

NYSE:SRI - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	932	N/A	N/A	N/A	1
12/31/2025	892	N/A	N/A	N/A	1
12/31/2024	895	N/A	N/A	N/A	1
9/30/2024	920	-7	10	39	N/A
6/30/2024	944	2	-6	27	N/A
3/31/2024	974	-4	-11	23	N/A
12/31/2023	976	-5	-34	5	N/A
9/30/2023	977	-8	-12	25	N/A
6/30/2023	966	-9	-15	20	N/A
3/31/2023	920	-14	-17	17	N/A
12/31/2022	900	-14	-25	7	N/A
9/30/2022	872	-20	-69	-41	N/A
6/30/2022	827	-32	-59	-31	N/A
3/31/2022	798	-4	-66	-39	N/A
12/31/2021	770	3	-63	-36	N/A
9/30/2021	757	13	-30	0	N/A
6/30/2021	751	30	-17	13	N/A
3/31/2021	659	-11	-15	18	N/A
12/31/2020	648	-8	-4	29	N/A
9/30/2020	649	-7	-20	13	N/A
6/30/2020	676	-7	-28	11	N/A
3/31/2020	799	54	-14	24	N/A
12/31/2019	834	60	-15	25	N/A
9/30/2019	855	68	17	54	N/A
6/30/2019	860	75	29	59	N/A
3/31/2019	859	50	38	65	N/A
12/31/2018	866	54	52	81	N/A
9/30/2018	863	61	45	75	N/A
6/30/2018	858	55	N/A	81	N/A
3/31/2018	846	49	N/A	79	N/A
12/31/2017	824	45	N/A	79	N/A
9/30/2017	790	75	N/A	79	N/A
6/30/2017	760	77	N/A	75	N/A
3/31/2017	738	79	N/A	74	N/A
12/31/2016	696	77	N/A	65	N/A
9/30/2016	678	35	N/A	75	N/A
6/30/2016	666	32	N/A	71	N/A
3/31/2016	645	28	N/A	60	N/A
12/31/2015	645	23	N/A	55	N/A
9/30/2015	657	-8	N/A	38	N/A
6/30/2015	665	-7	N/A	29	N/A
3/31/2015	662	-36	N/A	32	N/A
12/31/2014	661	-38	N/A	20	N/A
9/30/2014	663	-9	N/A	20	N/A
6/30/2014	654	-10	N/A	33	N/A
3/31/2014	662	17	N/A	28	N/A
12/31/2013	659	19	N/A	44	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van SRI boven de spaarquote ( 2.5% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van SRI naar verwachting sneller zal groeien dan de markt US

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van SRI naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: De omzet van SRI ( 0.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.8% per jaar).

Hoge groei-inkomsten: De omzet van SRI ( 0.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van SRI naar verwachting over 3 jaar hoog zal zijn

Stoneridge Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target decreased by 27% to US$18.50

Stoneridge, Inc. Updates Earnings Guidance for the Full Year 2024

Stoneridge, Inc. Revises Earnings Guidance for the Full Year 2024

Price target increased by 8.9% to US$27.50

Stoneridge, Inc. Provides Earnings Guidance for the Full Year 2024 and the Year 2028

Stoneridge, Inc. Provides Revenue Guidance for the Year 2024

Recent updates

Price target decreased by 27% to US$18.50

Some Stoneridge, Inc. (NYSE:SRI) Shareholders Look For Exit As Shares Take 34% Pounding

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Stoneridge, Inc. Updates Earnings Guidance for the Full Year 2024

Stoneridge, Inc. Announces Next MirrorEye® Program on New Freightliner Fifth Generation Cascadia

Stoneridge (NYSE:SRI) Is Finding It Tricky To Allocate Its Capital

We Like Stoneridge's (NYSE:SRI) Earnings For More Than Just Statutory Profit

New major risk - Revenue and earnings growth

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Stoneridge, Inc. Revises Earnings Guidance for the Full Year 2024

Stoneridge, Inc.(NYSE:SRI) dropped from Russell 3000 Growth Index

Price target increased by 8.9% to US$27.50

Stoneridge, Inc. Announces President of Electronics Division Changes, Effective September 1, 2024

President recently bought US$102k worth of stock

New major risk - Revenue and earnings growth

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

The Returns On Capital At Stoneridge (NYSE:SRI) Don't Inspire Confidence

Stoneridge, Inc., Annual General Meeting, May 14, 2024

Stoneridge, Inc. Appoints Troy Cooprider as Chief Technology Officer

Stoneridge, Inc.'s (NYSE:SRI) Shareholders Might Be Looking For Exit

New major risk - Revenue and earnings growth

Stoneridge, Inc. Provides Earnings Guidance for the Full Year 2024 and the Year 2028

Stoneridge's MirrorEye® Camera Monitor System Receives FMCSA Exemption Renewal

Stoneridge's MirrorEye® Camera Monitor System Receives FMCSA Exemption Renewal

These 4 Measures Indicate That Stoneridge (NYSE:SRI) Is Using Debt Extensively

Third quarter 2023 earnings: EPS exceeds analyst expectations

Stoneridge, Inc. Provides Revenue Guidance for the Year 2024

Returns On Capital Signal Difficult Times Ahead For Stoneridge (NYSE:SRI)

Here's Why Stoneridge (NYSE:SRI) Has A Meaningful Debt Burden

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 7.3% to US$25.25

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 7.3% to US$25.25

CTO & Chief Strategy Officer exercised options and sold US$174k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Stoneridge (NYSE:SRI) A Risky Investment?

Stoneridge, Inc. Announces Resignation of Jeffrey P. Draime from Board of Directors

Stoneridge, Inc. Announces Chief Executive Officer Changes

Stoneridge appoints former Aptiv executive Jim Zizelman as president, CEO

Insufficient new directors

Price target increased to US$27.75

Stoneridge, Inc. Updates Earnings Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Would Stoneridge (NYSE:SRI) Be Better Off With Less Debt?

Independent Director recently bought US$76k worth of stock

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Stoneridge, Inc. Revises Earnings Guidance for the Full Year 2022

Price target decreased to US$24.00

Stoneridge, Inc. Announces Management Changes

Stoneridge, Inc.(NYSE:SRI) dropped from Russell 2000 Value-Defensive Index

Stoneridge (NYSE:SRI) Is Making Moderate Use Of Debt

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$25.00

Stoneridge, Inc. Provides Earnings Guidance for the Year 2022

Insufficient new directors

Stoneridge, Inc., Annual General Meeting, May 17, 2022

Need To Know: Analysts Are Much More Bullish On Stoneridge, Inc. (NYSE:SRI) Revenues

CEO, President & Director recently bought US$243k worth of stock

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

Stoneridge (NYSE:SRI) Takes On Some Risk With Its Use Of Debt

Minda Corporation Limited (NSEI:MINDACORP) completed the acquisition of remaining 49% stake in Minda Stoneridge Instruments Ltd. from Stoneridge, Inc. (NYSE:SRI)

Investor sentiment improved over the past week

The Returns On Capital At Stoneridge (NYSE:SRI) Don't Inspire Confidence

Third quarter 2021 earnings released: US$0.38 loss per share (vs US$0.25 profit in 3Q 2020)

Price target decreased to US$36.00

Executive VP, CFO & Treasurer Robert Krakowiak has left the company

CTO & President of Electronics Division recently sold US$273k worth of stock

Chief Legal Officer & Secretary Thomas Dono has left the company